[1]Ganesh,Thota;Jiang,Jianxiong;Dingledine,Ray[EuropeanJournalofMedicinalChemistry,2014,vol.82,p.521-535]
[1]Patent:EP2940003,2015,A1.Locationinpatent:Paragraph0060
[1]ACSChemicalNeuroscience,2018,vol.9,p.328-345
1085300-74-8
112947-93-0
7665-66-9
305346-88-7
61981-79-1
54022-49-0 | Formyl-leurosine | AA00DD9Y | MFCD01726272
519055-62-0 | Tasisulam | AA00DDFJ | MFCD11973637
4362-40-7 | 4-(Chloromethyl)-2,2-dimethyl-1,3-dioxolane | AA00DDOM | MFCD00046097
4592-94-3 | 4-Bromobenzoylacetonitrile | AA00DDUY | MFCD00996063
533-15-3 | 2-(1-Methylpiperidin-2-yl)ethanol | AA00DE0M | MFCD00673141
5395-79-9 | (4-Chlorophenyl)(4-methylphenyl)methanone | AA00DE8Q | MFCD00625699
55513-19-4 | 1-(3-FLUOROBENZYL)PIPERAZINE | AA00DEDR | MFCD02242870
4627-10-5 | 4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane | AA00DEL5 | MFCD00066915
51534-37-3 | E-2-OCTADECENAL | AA00DERH | MFCD09055122
54393-21-4 | (Z)-3-AMino-2-Methyl-2-butenoic Acid Ethyl Ester | AA00DEZO | MFCD18379172